Last reviewed · How we verify

NCT06947837: Nurses

Study on the Influencing Mechanism and Promoting Strategies of Post-partum Nurses' Work Engagement

Completed Last updated 31 December 2025
What this trial tests

trial in Nurses in 200 participants. Completed in 20 December 2025.

Timeline
30 September 2025
Primary endpoint
20 December 2025
20 December 2025

Quick facts

Lead sponsorkeqin liu
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date30 September 2025
Primary completion20 December 2025
Estimated completion20 December 2025
Sites1 location across China

Conditions studied

Sponsor

keqin liu

Who can join

Adults 20 to 50, female only, with Nurses or Postpartum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to through the combination of longitudinal qualitative research and longitudinal quantitative research, the work experience changes of nurses returning to work after delivery were analyzed, and the changing trajectory and influencing mechanism of work involvement of nurses returning to work after delivery were explored.On this basis, combined with the existing literature, the promotion strategy of post-natal nurses' work involvement was constructed in order to improve the level of post-natal nurses' work involvement, help them better adapt to clinical nursing work, and improve the quality of nursing service.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Nurses

Currently open trials in the same condition.

Other keqin liu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06947837.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing